News

Villafana-led Medtech Firm Medical 21 Secures $20M in Financing

Friday, September 30, 2022
Medical device company Medical 21, founded on technology developed at the UI by Prof. Suresh Raghavan, announced that it has landed a $20 million commitment from an individual investor.

Viewpoint Molecular Targeting Announces Transformational Merger

Thursday, September 29, 2022
Viewpoint Molecular Targeting, UI start-up company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic imaging agents, today announced that it has entered into a definitive agreement to merge with Isoray, Inc (NYSE AMERICAN:ISR), a medical technology company and innovator in seed brachytherapy.

Cardio Diagnostics Announces Issuance of U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease

Friday, September 23, 2022
Cardio Diagnostics, a pioneering precision cardiovascular testing company founded by UI faculty Dr. Robert Philibert and UI graduate Dr. Meesha Dogan, announced that the U.S. Patent and Trademark Office has issued to the University of Iowa Research Foundation ("UIRF") U.S. Patent No. 11,414,704 titled COMPOSITIONS AND METHODS FOR DETECTING PREDISPOSITION TO CARDIOVASCULAR DISEASE, which is exclusively licensed to the Company from UIRF.

Digital Diagnostics Closes $75 million Series B Funding Round led by KKR

Tuesday, August 23, 2022
Digital Diagnostics, a leading artificial intelligence diagnostic health care technology company founded by UI faculty Dr. Michael Abramoff, today announced that it has successfully closed a $75 million Series B funding round.

Two companies co-founded by UI researchers secure a combined $62M in financing to advance disease therapies

The companies, Carbon Biosciences and hC Bioscience, are based on foundational research by University of Iowa (UI) professors John Engelhardt, Ziying Yan, Chris Ahern, and colleagues at other institutions.

Carbon Biosciences Launches with $38 Million Series A Financing to Advance Novel Gene Therapy Platform and Pipeline

Tuesday, June 21, 2022
Founded in part by University of Iowa gene therapy pioneers John F. Engelhardt, Ph.D. and Ziying Yan, Ph.D., along with Robert M. Kotin, Ph.D. and Longwood Fund, Carbon is expanding the gene therapy toolbox for the treatment of the world’s most devastating and difficult to treat diseases.

Mana Capital Acquisition Corp. and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics

Wednesday, June 1, 2022
Cardio Diagnostics, Inc. a UI start-up company and a pioneering precision cardiovascular medicine company, and Mana Capital Acquisition Corp., a special purpose acquisition company, announced that they have entered into a definitive business combination agreement that will result in Cardio Diagnostics becoming a publicly listed company.

Strong Demand for Lung Intelligence Accelerates VIDA's Growth

Wednesday, May 4, 2022
VIDA Diagnostics, Inc. (VIDA), a UI start-up company and the leader in lung and respiratory intelligence, announced it has secured financing as it scales up to support strong demand for its VIDA Intelligence Portal, an AI-powered solution that supports clinical trial decentralization and improves site recruitment, onboarding, staff training, image data management and data quality.

VIDA Expands Global Footprint into Japan with Market Authorization Through Partner Cairvo

Wednesday, April 13, 2022
VIDA Diagnostics, Inc, a UI start-up and leader in lung and respiratory intelligence, has received market authorization in Japan for its VIDA Insights® software, paving the way for lung care teams to begin using the solution at the point of care.

Firefly Photonics, LLC awarded $100,000 from Iowa Economic Development Authority

Thursday, March 24, 2022
Firefly Photonics, a UI start-up company, was awarded a Demonstration Fund loan from the Iowa Economic Development Authority to support commercialization of mid-wave infrared light emitting diodes (LED) and photodetectors (PD) used in small, battery-operated methane and carbon dioxide sensors.